Download PDF
J Pediatr Intensive Care 2019; 08(04): 242-246
DOI: 10.1055/s-0039-1693483
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Successful Management of Adolescent Bupropion Overdose with Intravenous Lipid Emulsion Therapy

Kasha Bornstein 
1   University of Miami Miller School of Medicine, Miami, Florida, United States
,
Tim Montrief
2   Department of Emergency Medicine, University of Miami, Jackson Memorial Hospital/Miller School of Medicine, Miami, United States
,
Mehruba Anwar Parris
2   Department of Emergency Medicine, University of Miami, Jackson Memorial Hospital/Miller School of Medicine, Miami, United States
› Author Affiliations Funding None.
Further Information

Publication History

15 May 2019

11 June 2019

Publication Date:
25 July 2019 (online)

    Permissions and Reprints

Abstract

Bupropion overdose in the pediatric setting poses significant potential for toxicity. We present the case of a 15-year-old female patient presenting with intentional bupropion overdose resulting in generalized tonic–clonic seizures, severe acidosis, vomiting, and tachycardia after ingestion of between 1,650 to 9,000 mg (24–133 mg/kg) of bupropion. The patient was admitted to pediatric intensive care unit (PICU) where toxicity was resolved promptly following administration of intravenous lipid emulsion (ILE) infusion. ILE is a first-line treatment for other forms of toxicity including unintended local anesthetic administration. ILE use is not a first-line treatment in this setting, but this case presents a positive subsequent patient outcome.

Keywords

Bupropion - Wellbutrin - lipid emulsion therapy - antidepressant - overdose

Note

This report describes a case of intentional severe bupropion overdose in an adolescent patient and successful management of sequelae with intravenous lipid emulsion therapy.


Authors' Contribution

M.A.P. and T.M. conceptualized the case report and provided edits and revision. K.B. drafted the initial manuscript and reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.


 

  • References

  • 1 Belson MG, Kelley TR. Bupropion exposures: clinical manifestations and medical outcome. J Emerg Med 2002; 23 (03) 223-230
    CrossrefPubMedGoogle Scholar
  • 2 Gosselin S, Hoegberg LC, Hoffman RS. , et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol (Phila) 2016; 54 (10) 899-923
    CrossrefPubMedGoogle Scholar
  • 3 Chhabra N, DesLauriers C, Wahl M, Bryant SM. Management of severe bupropion poisoning with intravenous lipid emulsion. Clin Toxicol (Phila) 2018; 56 (01) 51-54
    CrossrefPubMedGoogle Scholar
  • 4 Casey ER, Scott MG, Tang S, Mullins ME. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay. J Med Toxicol 2011; 7 (02) 105-108
    CrossrefPubMedGoogle Scholar
  • 5 Nelson JC, Spyker DA. Morbidity and mortality associated with medications used in the treatment of depression: an analysis of cases reported to U.S. Poison Control Centers, 2000–2014. Am J Psychiatry 2017; 174 (05) 438-450
    CrossrefPubMedGoogle Scholar
  • 6 Anez-Bustillos L, Dao DT, Baker MA, Fell GL, Puder M, Gura KM. Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract 2016; 31 (05) 596-609
    CrossrefPubMedGoogle Scholar
  • 7 Bupropion. Micromedex Solutions. Greenwood Village, CO: Truven Health Analytics. Available at: https://www.micromedexsolutions.com/micromedex2/librarian/CS/958B44/ND_PR/evidencexpert/ND_P/evidencexpert/DUPLICATIONSHIELDSYNC/5E4665/N . Updated 1/4/2019. Accessed May 8, 2019
    PubMed
  • 8 Boora K, Cummings MR, Marshall DR. Generalized seizure in three adolescents with bupropion overdose. J Child Adolesc Psychopharmacol 2010; 20 (02) 159-160
    CrossrefPubMedGoogle Scholar
  • 9 Zhu Y, Kolawole T, Jimenez XF. Atypical findings in massive bupropion overdose: a case report and discussion of psychopharmacologic issues. J Psychiatr Pract 2016; 22 (05) 405-409
    CrossrefPubMedGoogle Scholar
  • 10 Wellbutrin XL [package insert]. Research Triangle Park N. In. GlaxoSmithKline 2006. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018644s043lbl.pdf . Accessed May 8, 2019
    PubMed
  • 11 Spiller HA, Schaeffer SE. Multiple seizures after bupropion overdose in a small child. Pediatr Emerg Care 2008; 24 (07) 474-475
    CrossrefPubMedGoogle Scholar
  • 12 Heise CW, Skolnik AB, Raschke RA, Owen-Reece H, Graeme KA. Two cases of refractory cardiogenic shock secondary to bupropion successfully treated with veno-arterial extracorporeal membrane oxygenation. J Med Toxicol 2016; 12 (03) 301-304
    CrossrefPubMedGoogle Scholar
  • 13 Intralipid. [package insert]. Deerfield IL. Baxter. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017643s072,018449s039lbl.pdf . Accessed May 9, 2019
    PubMed
  • 14 Picard J, Meek T. Lipid emulsion to treat overdose of local anaesthetic: the gift of the glob. Anaesthesia 2006; 61 (02) 107-109
    CrossrefPubMedGoogle Scholar
  • 15 Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006; 105 (01) 217-218
    CrossrefPubMedGoogle Scholar
  • 16 Weinberg GL, Di Gregorio G, Ripper R. , et al. Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose. Anesthesiology 2008; 108 (05) 907-913
    CrossrefPubMedGoogle Scholar
  • 17 Rothschild L, Bern S, Oswald S, Weinberg G. Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med 2010; 18: 51
    CrossrefPubMedGoogle Scholar
  • 18 Kryshtal DO, Dawling S, Seger D, Knollmann BC. In vitro studies indicate intravenous lipid emulsion acts as lipid sink in verapamil poisoning. J Med Toxicol 2016; 12 (02) 165-171
    CrossrefPubMedGoogle Scholar
  • 19 Sirianni AJ, Osterhoudt KC, Calello DP. , et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 2008; 51 (04) 412-415 , 415.e1
    CrossrefPubMedGoogle Scholar
  • 20 Walter E, McKinlay J, Corbett J, Kirk-Bayley J. Review of management in cardiotoxic overdose and efficacy of delayed intralipid use. J Intensive Care Soc 2018; 19 (01) 50-55
    PubMedGoogle Scholar
  • 21 American College of Medical Toxicology. ACMT position statement: guidance for the use of intravenous lipid emulsion. J Med Toxicol 2017; 13 (01) 124-125
    CrossrefPubMedGoogle Scholar
  • 22 Weinberg Guy L. Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Anesthesiology 2012; 117 (01) 180-187
    CrossrefPubMedGoogle Scholar
  • 23 Bucklin MH, Gorodetsky RM, Wiegand TJ. Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose. Clin Toxicol (Phila) 2013; 51 (09) 896-898
    CrossrefPubMedGoogle Scholar
  • 24 Karcioglu O. Use of lipid emulsion therapy in local anesthetic overdose. Saudi Med J 2017; 38 (10) 985-993
    CrossrefPubMedGoogle Scholar
  • 25 Smolinske S, Hoffman RS, Villeneuve E, Hoegberg LCG, Gosselin S. Utilization of lipid emulsion therapy in fatal overdose cases: an observational study. Clin Toxicol (Phila) 2019; 57 (03) 197-202
    CrossrefPubMedGoogle Scholar
  • 26 Lee HMD, Archer JRH, Dargan PI, Wood DM. What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient?. Clin Toxicol 2015; 53 (03) 145-150
    CrossrefPubMedGoogle Scholar
  • 27 Christian MR, Pallasch EM, Wahl M, Mycyk MB. Lipid rescue 911: are poison centers recommending intravenous fat emulsion therapy for severe poisoning?. J Med Toxicol 2013; 9 (03) 231-234
    CrossrefPubMedGoogle Scholar
  • 28 Wu P, Juurlink D. Bupropion. In: Brent J, Burkhart K, Dargan P, Hatten B, Megarbane B, Palmer R. , eds. In: Critical Care Toxicology, 2nd ed. Switzerland: Springer International Publishing; 2016: 1-10
    Google Scholar
  • 29 Shah ASV, Eddleston M. Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures?. Clin Toxicol 2010; 48 (08) 800-805
    CrossrefPubMedGoogle Scholar
  • 30 Wills BK, Zell-Kanter M, Aks SE. Bupropion-associated QRS prolongation unresponsive to sodium bicarbonate therapy. Am J Ther 2009; 16 (02) 193-196
    CrossrefPubMedGoogle Scholar
  • 31 Caillier B, Pilote S, Castonguay A. , et al. QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile. Fundam Clin Pharmacol 2012; 26 (05) 599-608
    CrossrefPubMedGoogle Scholar
  • 32 Worrall SP, Almond MK, Dhillon S. Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study. Nephron Clin Pract 2004; 97 (03) c83-c89
    CrossrefPubMedGoogle Scholar
  • 33 Tolentino S, Gharpure V, Tsifansky M. 1173: Successful use of lipid infusion and plasmapheresis after massive bupropion overdose. Crit Care Med 2013; 41 (12) A298
    PubMedGoogle Scholar
  • 34 Levine M, Hoffman RS, Lavergne V. , et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol (Phila) 2016; 54 (03) 194-221
    CrossrefPubMedGoogle Scholar
  • 35 Disel NR, Akpinar AA, Sebe A. , et al. Therapeutic plasma exchange in poisoning: 8 years' experience of a university hospital. Am J Emerg Med 2015; 33 (10) 1391-1395
    CrossrefPubMedGoogle Scholar